BOCHK Asset Management Ltd Boosts Stock Position in UnitedHealth Group Incorporated $UNH

Key Points

• BOCHK Asset Management boosted its UnitedHealth stake by 416.7% in Q4 to 5,890 shares (about $1.94M), making UNH roughly 0.5% of BOCHK's holdings and its 17th-largest position.
• Large institutions have big, growing exposures—Berkshire Hathaway initiated an approximately $1.57B stake and firms like Capital Research and Capital World hold multi-billion-dollar positions—leaving institutional ownership at about 87.86%.
• Following a CMS increase to Medicare Advantage rates that helped spark a rally, analyst sentiment is mixed: the consensus is a "Moderate Buy" with a $363.42 target, but several firms trimmed price targets and flagged margin and medical-cost risks.

BOCHK Asset Management Ltd increased its stake in shares of UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 416.7% in the fourth quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor owned 5,890 shares of the healthcare conglomerate's stock after purchasing an additional 4,750 shares during the quarter. UnitedHealth Group makes up approximately 0.5% of BOCHK Asset Management Ltd's holdings, making the stock its 17th largest holding. BOCHK Asset Management Ltd's holdings in UnitedHealth Group were worth $1,944,000 at the end of the most recent reporting period.

A number of other hedge funds and other institutional investors have also recently added to or reduced their stakes in UNH. Capital Research Global Investors increased its position in UnitedHealth Group by 126.9% during the 3rd quarter. Capital Research Global Investors now owns 13,042,049 shares of the healthcare conglomerate's stock worth $4,503,419,000 after purchasing an additional 7,293,009 shares in the last quarter. Berkshire Hathaway Inc purchased a new stake in UnitedHealth Group in the 2nd quarter valued at about $1,572,193,000. Capital World Investors grew its holdings in UnitedHealth Group by 18.8% in the 3rd quarter. Capital World Investors now owns 21,766,922 shares of the healthcare conglomerate's stock valued at $7,516,107,000 after buying an additional 3,439,182 shares during the period. Capital International Investors grew its holdings in UnitedHealth Group by 11.1% in the 3rd quarter. Capital International Investors now owns 17,499,949 shares of the healthcare conglomerate's stock valued at $6,042,710,000 after buying an additional 1,747,337 shares during the period. Finally, Lone Pine Capital LLC purchased a new stake in UnitedHealth Group in the 2nd quarter valued at about $528,273,000. Hedge funds and other institutional investors own 87.86% of the company's stock.

Analyst Upgrades and Downgrades

Several research firms have commented on UNH. JPMorgan Chase & Co. lowered their price target on UnitedHealth Group from $425.00 to $389.00 and set an "overweight" rating for the company in a report on Monday, February 2nd. Royal Bank Of Canada lowered their price target on UnitedHealth Group from $408.00 to $361.00 and set an "outperform" rating for the company in a report on Wednesday, January 28th. Leerink Partners decreased their target price on UnitedHealth Group from $410.00 to $345.00 and set an "outperform" rating for the company in a report on Wednesday, January 28th. UBS Group decreased their target price on UnitedHealth Group from $430.00 to $410.00 and set a "buy" rating for the company in a report on Wednesday, January 28th. Finally, Sanford C. Bernstein boosted their target price on UnitedHealth Group from $405.00 to $411.00 and gave the stock an "outperform" rating in a report on Tuesday. One investment analyst has rated the stock with a Strong Buy rating, eighteen have issued a Buy rating, eight have given a Hold rating and two have given a Sell rating to the company's stock. Based on data from MarketBeat, UnitedHealth Group presently has an average rating of "Moderate Buy" and a consensus target price of $363.42.

UnitedHealth Group News Roundup

Here are the key news stories impacting UnitedHealth Group this week:

• Positive Sentiment: CMS raised Medicare Advantage rates more than expected, which analysts say could add meaningful revenue and operating profit for insurers and helped spark the recent multi‑day rally in UNH. UnitedHealth Could Reprice Soon: The Catalyst Is Here
• Positive Sentiment: Market reaction to the CMS decision drove a sharp jump in UNH shares and prompted positive analyst re‑ratings and momentum in estimates. UnitedHealth (UNH) Soars 9.37% on Medicare Reimbursement Rate Jump
• Positive Sentiment: Sanford C. Bernstein raised its UNH price target to $411 and other houses (including HSBC) issued friendlier views/upgrades, supporting the stock's lift. Sanford C. Bernstein Boosts UnitedHealth Group Price Target to $411.00
• Neutral Sentiment: Zacks and other outlets note heightened investor attention and inclusion in top‑stock lists — useful for flows and visibility but not a direct earnings driver. UnitedHealth Group Incorporated (UNH) is Attracting Investor Attention: Here is What You Should Know
• Neutral Sentiment: Estimate revisions are slightly constructive (some houses nudging FY forecasts higher), but consensus still reflects mixed views on 2026/27 margins. The Zacks Analyst Blog Highlights Procter & Gamble, Toyota Motor, UnitedHealth...
• Negative Sentiment: Several analysts and commentators warn the Medicare Advantage bump may be partially priced in and that upcoming earnings (and ongoing medical‑cost/margin pressures) could reverse gains. Expect volatility into the report. UnitedHealth Stock Jumps on Better‑Than‑Expected Medicare Advantage Rates. Here's Why the Rally Might Be Short‑Lived
• Negative Sentiment: Critical takes argue the CMS move doesn’t eliminate downside risks (policy/regulatory uncertainty, higher medical costs); a skeptical piece cautions investors not to over‑react. UnitedHealth Group: Don't Drink The CMS Kool‑Aid

UnitedHealth Group Stock Up 0.4%

Shares of NYSE:UNH opened at $307.09 on Friday. The stock has a market capitalization of $278.74 billion, a P/E ratio of 23.28, a PEG ratio of 1.41 and a beta of 0.40. UnitedHealth Group Incorporated has a 1 year low of $234.60 and a 1 year high of $606.36. The stock has a 50-day simple moving average of $282.66 and a 200-day simple moving average of $318.87. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.79 and a current ratio of 0.79.

UnitedHealth Group (NYSE:UNH - Get Free Report) last released its quarterly earnings results on Tuesday, January 27th. The healthcare conglomerate reported $2.11 earnings per share for the quarter, topping analysts' consensus estimates of $2.09 by $0.02. The firm had revenue of $113.73 billion during the quarter, compared to analysts' expectations of $113.38 billion. UnitedHealth Group had a return on equity of 14.79% and a net margin of 2.69%.UnitedHealth Group's quarterly revenue was up 12.3% compared to the same quarter last year. During the same quarter in the prior year, the business earned $6.81 EPS. UnitedHealth Group has set its FY 2026 guidance at 17.750- EPS. Equities analysts forecast that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Tuesday, March 17th. Shareholders of record on Monday, March 9th were issued a $2.21 dividend. This represents a $8.84 dividend on an annualized basis and a yield of 2.9%. The ex-dividend date was Monday, March 9th. UnitedHealth Group's dividend payout ratio is currently 67.02%.

About UnitedHealth Group

UnitedHealth Group Inc is a diversified health care company headquartered in Minnetonka, Minnesota, that operates two primary business platforms: UnitedHealthcare and Optum. Founded in 1977, the company provides a broad range of health benefits and health care services to individuals, employers, governmental entities and other organizations. Its operations span commercial employer-sponsored plans, individual and Medicare and Medicaid programs, and services for customers and health systems in the United States and selected international markets.

UnitedHealthcare is the company's benefits business, administering health plans and networks, managing provider relationships, and offering coverage products for employers, individuals, and government-sponsored programs.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.